Skip to main content Accessibility help
×
Home
  • Print publication year: 2015
  • Online publication date: February 2015

54 - Fertility preservation in a female of reproductive age with ovarian cancer

Related content

Powered by UNSILO

References

1. American Cancer Society. Cancer Facts and Figures 2012. Atlanta, GA: American Cancer Society; 2012. Available at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf. Accessed October 11, 2012.
2. You W, Dainty LA, Rose GS, Krivak T, McHale MT, Olsen CH, Elkas JC. Gynecologic malignancies in women aged less than 25 years. Obstet Gynecol 2005; 105: 1405–9.
3. National Comprehensive Cancer Network. Clinical practical guideline in oncology, uterine cancer, V.1. Fort Washington, PA: National Comprehensive Cancer Network; 2012. Available at: http://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf. Accessed October 11, 2012.
4. Williams S, Blessing JA, Liao SY, Ball H, Hanjani P. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. J Clin Oncol 1994; 12: 701–6.
5. Pectasides D, Pectasides E, Kassanos D. Germ cell tumors of the ovary. Cancer Treat Rev 2008; 34: 427–41.
6. Gershenson DM, Miller AM, Champion VL, Monahan PO, Zhao Q, Cella D, Williams SD; Gynecologic Oncology Group. Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study. J Clin Oncol 2007; 25: 2792–7.
7. Chen H, Li J, Cui T, Hu L. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev 2011; (11): CD008018.